News

With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff ...
Stifel’s Barry Bannister says stocks are due for a big drop and thinks investors should play defense with staples and ...
Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...
Wall Street’s record-setting rally is due for a reality check, according to the latest report from Stifel’s Barry Bannister ...
The embattled Richmond businessman was largely defeated last month in his attempt to overturn his 2021 criminal fraud ...
Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on ADENTRA today and set a price target of C$44.00. The company’s shares closed last Wednesday at $21.78. Elevate You ...
U.S. stocks edged back from their record heights on Monday in Wall Street's final moves before an upcoming update on ...
U.S. stocks edged back from their record heights in Wall Street’s final moves before an upcoming update on inflation.
Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...
The Bethlehem Area School District Board of Directors forwarded various high school and middle school improvement plans for ...